382 related articles for article (PubMed ID: 15164594)
1. [Relation between benign prostatic hyperplasia and obesity and estrogen].
Matsuda T; Abe H; Suda K
Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
[TBL] [Abstract][Full Text] [Related]
2. [Relation between the prostatic tissue components and natural history, estrogen receptor].
Matsuda T; Abe H; Suda K
Rinsho Byori; 2003 Dec; 51(12):1180-3. PubMed ID: 14743740
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
[TBL] [Abstract][Full Text] [Related]
4. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
5. Obesity and benign prostatic enlargement: a large observational study in China.
Xie LP; Bai Y; Zhang XZ; Zheng XY; Yao KS; Xu L; Zeegers MP
Urology; 2007 Apr; 69(4):680-4. PubMed ID: 17445651
[TBL] [Abstract][Full Text] [Related]
6. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
[TBL] [Abstract][Full Text] [Related]
7. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
Parsons JK; Sarma AV; McVary K; Wei JT
J Urol; 2009 Dec; 182(6 Suppl):S27-31. PubMed ID: 19846130
[TBL] [Abstract][Full Text] [Related]
8. Impact of prostate size and body mass index on perioperative morbidity after laparoscopic radical prostatectomy.
Singh A; Fagin R; Shah G; Shekarriz B
J Urol; 2005 Feb; 173(2):552-4. PubMed ID: 15643251
[TBL] [Abstract][Full Text] [Related]
9. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
Marks LS; Roehrborn CG; Wolford E; Wilson TH
J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
[TBL] [Abstract][Full Text] [Related]
10. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
11. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
Loeb S; Yu X; Nadler RB; Roehl KA; Han M; Hawkins SA; Catalona WJ
J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013
[TBL] [Abstract][Full Text] [Related]
12. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
13. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
[TBL] [Abstract][Full Text] [Related]
14. Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.
Motamedinia P; Korets R; Spencer BA; Benson MC; McKiernan JM
Urology; 2008 Nov; 72(5):1106-10. PubMed ID: 18602142
[TBL] [Abstract][Full Text] [Related]
15. Holmium laser enucleation of the prostate--outcomes independent of prostate size?
Humphreys MR; Miller NL; Handa SE; Terry C; Munch LC; Lingeman JE
J Urol; 2008 Dec; 180(6):2431-5; discussion 2435. PubMed ID: 18930490
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the leptin and leptin receptor expressions in prostate tissues.
Hoon Kim J; Lee SY; Myung SC; Kim YS; Kim TH; Kim MK
Asian J Androl; 2008 Nov; 10(6):923-8. PubMed ID: 18958356
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic extraperitoneal radical prostatectomy in complex surgical cases.
Rodriguez AR; Kapoor R; Pow-Sang JM
J Urol; 2007 May; 177(5):1765-70. PubMed ID: 17437812
[TBL] [Abstract][Full Text] [Related]
18. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
[TBL] [Abstract][Full Text] [Related]
19. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
Siddiqui SA; Inman BA; Sengupta S; Slezak JM; Bergstralh EJ; Leibovich BC; Zincke H; Blute ML
Cancer; 2006 Aug; 107(3):521-9. PubMed ID: 16773619
[TBL] [Abstract][Full Text] [Related]
20. Phytoestrogen tissue levels in benign prostatic hyperplasia and prostate cancer and their association with prostatic diseases.
Brössner C; Petritsch K; Fink K; Auprich M; Madersbacher S; Adlercreutz H; Rehak P; Petritsch P
Urology; 2004 Oct; 64(4):707-11. PubMed ID: 15491706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
